Cidara Therapeutics (CDTX) announced that Nicole Davarpanah, M.D., J.D. has been promoted to chief medical officer, CMO, and Corrina Pavetto has been promoted to senior vice president, clinical development, effective May 1, 2025.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDTX:
- Elicio Therapeutics appoints Preetam Shah as chief strategy, financial officer
- Positive Buy Rating for Cidara Therapeutics Driven by Promising CD388 Development and Safety Profile
- Cidara Therapeutics to present on CD388 at ICAR 2025
- Cidara Therapeutics: CD388 preclinical data published in Nature Microbiology
- Cidara Therapeutics initiated with an Outperform at Citizens JMP
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue